Michael S Hearne insider trades

Open-market stock purchases and sales by Michael S Hearne, Chief Financial Officer at Aurinia Pharmaceuticals Inc, from SEC Form 4 filings since Nov 30, 2018.

Recent trades

DateStockTradeValue
May 18, 2026AUPH Aurinia Pharmaceuticals IncBought (not open market)—
May 18, 2026AUPH Aurinia Pharmaceuticals IncBought (not open market)—

Companies traded

  • AUPH Aurinia Pharmaceuticals Inc: other filings, last May 18, 2026
  • LJPC LA Jolla Pharmaceutical Co: 18 buys, 5 sales, last Aug 22, 2022
  • ODT Odonate Therapeutics, Inc: other filings, last Mar 15, 2021

Get free alerts when Michael S Hearne files a new trade →